1. Home
  2. RDNT vs BLCO Comparison

RDNT vs BLCO Comparison

Compare RDNT & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RadNet Inc.

RDNT

RadNet Inc.

HOLD

Current Price

$77.71

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$17.17

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDNT
BLCO
Founded
1985
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical Specialities
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
6.0B
IPO Year
1986
2022

Fundamental Metrics

Financial Performance
Metric
RDNT
BLCO
Price
$77.71
$17.17
Analyst Decision
Strong Buy
Hold
Analyst Count
5
14
Target Price
$83.60
$17.31
AVG Volume (30 Days)
1.0M
352.7K
Earning Date
11-09-2025
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,969,599,000.00
$4,976,000,000.00
Revenue This Year
$11.77
$8.06
Revenue Next Year
$10.76
$5.79
P/E Ratio
N/A
N/A
Revenue Growth
11.09
6.23
52 Week Low
$45.00
$10.45
52 Week High
$85.84
$18.34

Technical Indicators

Market Signals
Indicator
RDNT
BLCO
Relative Strength Index (RSI) 55.94 58.18
Support Level $70.31 $16.22
Resistance Level $73.52 $17.26
Average True Range (ATR) 3.00 0.34
MACD 0.36 -0.06
Stochastic Oscillator 92.67 83.97

Price Performance

Historical Comparison
RDNT
BLCO

About RDNT RadNet Inc.

RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: